Ads
related to: lymphoma survival rate- See How It Works
Discover How This FDA-Approved
Treatment Works
- Clinical Trial Results
Learn More About
Treatment Options
- See How It Works
Search results
New lung cancer pill could ‘stop disease in its tracks’
Daily Telegraph· 7 days agoScientists have hailed the drug, called lorlatinib, for its “off the charts” results after a trial...
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 7 days agoAdministered as a one-time infusion, the cell therapy’s single dose contains 90 to 110...MCL....
Study: 33% Of New York Residents Have Greater Risk Of Cancer
New Jersey 101.5 FM· 6 days agoA new study offered grim news for many New York State residents.
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 7 days ago“Today, thanks to immunotherapy, survival rates are around 40 per cent.” But cancers are wily: they...
Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial
MedPage Today· 6 days agoReplacing chemotherapy with a targeted agent resulted in a better tolerated regimen for advanced...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 14 hours agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
Clinical trials show promise in treating central n | Newswise
Newswise· 6 days agoDana-Farber Cancer Institute researchers are leading 3 separate studies with encouraging results in treating patients with central nervous system (CNS) lym
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
Zacks via Yahoo Finance· 2 days agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
Triplet Notches Survival Win in Heavily Pretreated DLBCL
MedPage Today· 5 days agoBenefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant
Pfizer Study Shows Lorbrena Reduces Chances of Lung Cancer Getting Worse
Morningstar· 7 days agoThe drugmaker disclosed results from a Phase 3 trial evaluating Lorbrena compared to Xalkori in people with previously untreated, anaplastic lymphoma kinase-positive advanced ...
Ads
related to: lymphoma survival rate